QQQ   423.96 (-0.44%)
AAPL   166.97 (-0.61%)
MSFT   405.43 (-1.56%)
META   501.94 (+1.57%)
GOOGL   156.24 (+0.50%)
AMZN   179.21 (-1.14%)
TSLA   150.93 (-2.91%)
NVDA   846.26 (+0.70%)
AMD   154.65 (+0.41%)
NIO   4.01 (+2.56%)
BABA   68.88 (+0.09%)
T   16.24 (+0.74%)
F   12.02 (-0.17%)
MU   112.74 (-3.09%)
GE   153.92 (-1.12%)
CGC   8.05 (+24.04%)
DIS   113.02 (+0.07%)
AMC   2.92 (-2.01%)
PFE   25.33 (-0.35%)
PYPL   62.18 (-1.71%)
XOM   118.25 (-0.32%)
QQQ   423.96 (-0.44%)
AAPL   166.97 (-0.61%)
MSFT   405.43 (-1.56%)
META   501.94 (+1.57%)
GOOGL   156.24 (+0.50%)
AMZN   179.21 (-1.14%)
TSLA   150.93 (-2.91%)
NVDA   846.26 (+0.70%)
AMD   154.65 (+0.41%)
NIO   4.01 (+2.56%)
BABA   68.88 (+0.09%)
T   16.24 (+0.74%)
F   12.02 (-0.17%)
MU   112.74 (-3.09%)
GE   153.92 (-1.12%)
CGC   8.05 (+24.04%)
DIS   113.02 (+0.07%)
AMC   2.92 (-2.01%)
PFE   25.33 (-0.35%)
PYPL   62.18 (-1.71%)
XOM   118.25 (-0.32%)
QQQ   423.96 (-0.44%)
AAPL   166.97 (-0.61%)
MSFT   405.43 (-1.56%)
META   501.94 (+1.57%)
GOOGL   156.24 (+0.50%)
AMZN   179.21 (-1.14%)
TSLA   150.93 (-2.91%)
NVDA   846.26 (+0.70%)
AMD   154.65 (+0.41%)
NIO   4.01 (+2.56%)
BABA   68.88 (+0.09%)
T   16.24 (+0.74%)
F   12.02 (-0.17%)
MU   112.74 (-3.09%)
GE   153.92 (-1.12%)
CGC   8.05 (+24.04%)
DIS   113.02 (+0.07%)
AMC   2.92 (-2.01%)
PFE   25.33 (-0.35%)
PYPL   62.18 (-1.71%)
XOM   118.25 (-0.32%)
QQQ   423.96 (-0.44%)
AAPL   166.97 (-0.61%)
MSFT   405.43 (-1.56%)
META   501.94 (+1.57%)
GOOGL   156.24 (+0.50%)
AMZN   179.21 (-1.14%)
TSLA   150.93 (-2.91%)
NVDA   846.26 (+0.70%)
AMD   154.65 (+0.41%)
NIO   4.01 (+2.56%)
BABA   68.88 (+0.09%)
T   16.24 (+0.74%)
F   12.02 (-0.17%)
MU   112.74 (-3.09%)
GE   153.92 (-1.12%)
CGC   8.05 (+24.04%)
DIS   113.02 (+0.07%)
AMC   2.92 (-2.01%)
PFE   25.33 (-0.35%)
PYPL   62.18 (-1.71%)
XOM   118.25 (-0.32%)

Ventas (VTR) Stock Price, News & Analysis

$42.68
+0.45 (+1.07%)
(As of 03:09 PM ET)
Today's Range
$42.05
$42.84
50-Day Range
$41.67
$45.58
52-Week Range
$39.33
$50.99
Volume
972,844 shs
Average Volume
2.40 million shs
Market Capitalization
$17.24 billion
P/E Ratio
N/A
Dividend Yield
4.22%
Price Target
$51.54

Ventas MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.75 Rating Score
Upside/​Downside
21.4% Upside
$51.54 Price Target
Short Interest
Healthy
1.57% of Shares Sold Short
Dividend Strength
Moderate
Based on Four Factors
Sustainability
-2.06
Upright™ Environmental Score
News Sentiment
0.37mentions of Ventas in the last 14 days
Based on 7 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
6.67%
From $3.15 to $3.36 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.02 out of 5 stars

Finance Sector

315th out of 832 stocks

Real Estate Investment Trusts Industry

58th out of 178 stocks

VTR stock logo

About Ventas Stock (NYSE:VTR)

Ventas Inc. (NYSE: VTR) is a leading S&P 500 real estate investment trust focused on delivering strong, sustainable shareholder returns by enabling exceptional environments that benefit a large and growing aging population. The Company's growth is fueled by its senior housing communities, which provide valuable services to residents and enable them to thrive in supported environments. Ventas leverages its unmatched operational expertise, data-driven insights from its Ventas Operational InsightsTM platform, extensive relationships and strong financial position to achieve its goal of delivering outsized performance across approximately 1,400 properties. The Ventas portfolio is composed of senior housing communities, outpatient medical buildings, research centers and healthcare facilities in North America and the United Kingdom. The Company benefits from a seasoned team of talented professionals who share a commitment to excellence, integrity and a common purpose of helping people live longer, healthier, happier lives.

VTR Stock Price History

VTR Stock News Headlines

Henry Kissinger’s chilling AI warning
Not long before his death in 2023, Henry Kissinger wrote about a "world of potentially total destructiveness and substantial uncertainty." He was talking about the advent of generative artificial intelligence (AI)... And how we are woefully unprepared for the consequences this technology could bring.
Analyzing Ventas (NYSE:VTR) and PotlatchDeltic (NASDAQ:PCH)
Henry Kissinger’s chilling AI warning
Not long before his death in 2023, Henry Kissinger wrote about a "world of potentially total destructiveness and substantial uncertainty." He was talking about the advent of generative artificial intelligence (AI)... And how we are woefully unprepared for the consequences this technology could bring.
Ventas Issues Business Update
Guru Fundamental Report for VTR
(VTR) - Analyzing Ventas's Short Interest
Cracking The Code: Understanding Analyst Reviews For Ventas
VTR Nov 2024 40.000 put
VTR Apr 2024 40.000 put
Ventas Inc.
VTR Mar 2024 25.000 call
We Have a Lot of Access to Capital: Ventas CEO
See More Headlines
Receive VTR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ventas and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/09/2023
Ex-Dividend for 4/18 Dividend
3/28/2024
Today
4/18/2024
Dividend Payable
4/18/2024
Next Earnings (Confirmed)
5/01/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Finance
Industry
Real estate investment trusts
Sub-Industry
Specialized REITs
CUSIP
92276F10
Employees
486
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$51.54
High Stock Price Target
$60.00
Low Stock Price Target
$46.00
Potential Upside/Downside
+22.0%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.75
Research Coverage
12 Analysts

Profitability

Net Income
$-40,970,000.00
Pretax Margin
-2.57%

Debt

Sales & Book Value

Annual Sales
$4.50 billion
Cash Flow
$3.31 per share
Book Value
$23.72 per share

Miscellaneous

Free Float
400,009,000
Market Cap
$17.06 billion
Optionable
Optionable
Beta
1.26

Social Links

12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Key Executives

Should I Buy Ventas Stock? VTR Pros and Cons Explained

Pros

Here are some ways that investors could benefit from investing in Ventas, Inc.:

  • Ventas, Inc. has a strong focus on delivering sustainable shareholder returns, which can provide long-term financial growth for investors.
  • The company's operational expertise and data-driven insights from Ventas Operational InsightsTM platform can lead to informed investment decisions and potentially higher returns.
  • Ventas' diverse portfolio of senior housing communities, outpatient medical buildings, research centers, and healthcare facilities in North America and the United Kingdom offers investors exposure to various segments of the real estate market.
  • Recent analyst upgrades and positive ratings on Ventas stock indicate a favorable outlook, potentially attracting more investors and driving stock price growth.
  • With a commitment to excellence, integrity, and improving the quality of life for residents, Ventas aligns with socially responsible investing principles, appealing to ethically conscious investors.

Cons

Investors should be bearish about investing in Ventas, Inc. for these reasons:

  • Market volatility and economic uncertainties can impact the real estate sector, potentially affecting Ventas' performance and stock price.
  • Regulatory changes or shifts in healthcare policies could pose risks to Ventas' operations and financial stability.
  • Competition within the real estate investment trust (REIT) industry may limit Ventas' ability to differentiate itself and maintain market share.
  • Changes in interest rates can influence the cost of capital for Ventas, impacting its profitability and investment attractiveness.
  • External factors such as natural disasters or global events can disrupt operations and property values, affecting Ventas' financial performance.
These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Thursday, April 11, 2024. Please send any questions or comments about these Ventas pros and cons to contact@marketbeat.com.

VTR Stock Analysis - Frequently Asked Questions

Should I buy or sell Ventas stock right now?

12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Ventas in the last twelve months. There are currently 3 hold ratings and 9 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" VTR shares.
View VTR analyst ratings
or view top-rated stocks.

What is Ventas' stock price target for 2024?

12 brokers have issued twelve-month target prices for Ventas' stock. Their VTR share price targets range from $46.00 to $60.00. On average, they anticipate the company's share price to reach $51.54 in the next year. This suggests a possible upside of 21.4% from the stock's current price.
View analysts price targets for VTR
or view top-rated stocks among Wall Street analysts.

How have VTR shares performed in 2024?

Ventas' stock was trading at $49.84 at the beginning of the year. Since then, VTR stock has decreased by 14.8% and is now trading at $42.44.
View the best growth stocks for 2024 here
.

When is Ventas' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 1st 2024.
View our VTR earnings forecast
.

How can I listen to Ventas' earnings call?

Ventas will be holding an earnings conference call on Thursday, May 2nd at 10:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at 609-800-9909 with passcode "7655497".

How were Ventas' earnings last quarter?

Ventas, Inc. (NYSE:VTR) released its quarterly earnings results on Thursday, February, 9th. The real estate investment trust reported ($0.11) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.72 by $0.83. The real estate investment trust earned $1.05 billion during the quarter, compared to analyst estimates of $1.04 billion. Ventas had a negative trailing twelve-month return on equity of 0.41% and a negative net margin of 0.91%. The company's quarterly revenue was up 2.8% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.73 EPS.
Read the conference call transcript
.

How often does Ventas pay dividends? What is the dividend yield for Ventas?

Ventas announced a quarterly dividend on Tuesday, March 12th. Stockholders of record on Monday, April 1st will be paid a dividend of $0.45 per share on Thursday, April 18th. This represents a $1.80 annualized dividend and a dividend yield of 4.24%. The ex-dividend date of this dividend is Thursday, March 28th.
Read our dividend analysis for VTR
.

Is Ventas a good dividend stock?

Ventas (NYSE:VTR) pays an annual dividend of $1.80 per share and currently has a dividend yield of 4.32%. VTR has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer.
Read our dividend analysis for VTR.

What guidance has Ventas issued on next quarter's earnings?

Ventas updated its FY 2024 earnings guidance on Thursday, April, 4th. The company provided earnings per share guidance of 3.070-3.180 for the period, compared to the consensus estimate of 3.150. The company issued revenue guidance of -.

What is Debra A. Cafaro's approval rating as Ventas' CEO?

20 employees have rated Ventas Chief Executive Officer Debra A. Cafaro on Glassdoor.com. Debra A. Cafaro has an approval rating of 89% among the company's employees.

What other stocks do shareholders of Ventas own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Ventas investors own include AT&T (T), Verizon Communications (VZ), Realty Income (O), Coca-Cola (KO), Johnson & Johnson (JNJ), Enterprise Products Partners (EPD), Cisco Systems (CSCO), AbbVie (ABBV), Exxon Mobil (XOM) and Pfizer (PFE).

Who are Ventas' major shareholders?

Ventas' stock is owned by a variety of institutional and retail investors. Top institutional investors include Reinhart Partners LLC. (0.06%), Vert Asset Management LLC (0.04%), Gilman Hill Asset Management LLC (0.02%), Thomasville National Bank (0.02%), Sarasin & Partners LLP (0.02%) and Pensionfund DSM Netherlands (0.02%). Insiders that own company stock include Debra A Cafaro, Debra A Cafaro and Walter C Rakowich.
View institutional ownership trends
.

How do I buy shares of Ventas?

Shares of VTR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:VTR) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners